Literature DB >> 10871384

Rapid purification of protein complexes from mammalian cells.

D Medina1, N Moskowitz, S Khan, S Christopher, J Germino.   

Abstract

The evaluation of the protein binding partner(s) of biologically important proteins is currently an area of intense research, especially since the development of the yeast two-hybrid assay. However, not all protein-protein interactions uncovered by this assay are biologically relevant and another confirmatory assay must be performed. Ideally, this assay should be rapid, versatile and performed under conditions which mimic the 'normal' physiological state as closely as possible. Towards this goal, we have constructed two eukaryotic expression vectors that facilitate the purification of a protein of interest, along with any associated proteins, from mammalian cells. These vectors incorporate the following features: (i) a tetracycline-responsive promoter so that the level of protein production can be regulated; (ii) an N-terminal glutathione S-transferase tag or a triple repeat of the HA1 epitope, to facilitate purification of the protein either by glutathione affinity chromatography or immunoprecipitation, respectively, followed by a multiple cloning site; (iii) the gene for the enhanced green fluorescent protein (for detection of the presence of the fusion protein and subcellular localization); (iv) a puromycin marker for the selection of stable transformants; (v) a truncated EBNA protein and oriP sequence for episomal replication of the vector. These latter two features permit expansion of small cultures of transfected cells under puromycin selection, thereby increasing the amount of tagged protein that can be purified. We show that these vectors can be used to direct the doxycycline-inducible expression of tagged proteins and to recover tagged CIP1-p21 protein complexes from HeLa cells. Furthermore, we show that these tagged p21-purified complexes contain both cyclin A and Cdk2, which are known to interact with p21, but not beta-actin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10871384      PMCID: PMC102746          DOI: 10.1093/nar/28.12.e61

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  15 in total

1.  STAM, signal transducing adaptor molecule, is associated with Janus kinases and involved in signaling for cell growth and c-myc induction.

Authors:  T Takeshita; T Arita; M Higuchi; H Asao; K Endo; H Kuroda; N Tanaka; K Murata; N Ishii; K Sugamura
Journal:  Immunity       Date:  1997-04       Impact factor: 31.745

2.  Analysis of wild-type and mutant p21WAF-1 gene activities.

Authors:  J Lin; C Reichner; X Wu; A J Levine
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

3.  Efficient and rapid affinity purification of proteins using recombinant fusion proteases.

Authors:  P A Walker; L E Leong; P W Ng; S H Tan; S Waller; D Murphy; A G Porter
Journal:  Biotechnology (N Y)       Date:  1994-06

4.  Cloning of a novel signal-transducing adaptor molecule containing an SH3 domain and ITAM.

Authors:  T Takeshita; T Arita; H Asao; N Tanaka; M Higuchi; H Kuroda; K Kaneko; H Munakata; Y Endo; T Fujita; K Sugamura
Journal:  Biochem Biophys Res Commun       Date:  1996-08-23       Impact factor: 3.575

5.  Hrs is associated with STAM, a signal-transducing adaptor molecule. Its suppressive effect on cytokine-induced cell growth.

Authors:  H Asao; Y Sasaki; T Arita; N Tanaka; K Endo; H Kasai; T Takeshita; Y Endo; T Fujita; K Sugamura
Journal:  J Biol Chem       Date:  1997-12-26       Impact factor: 5.157

6.  FACS-optimized mutants of the green fluorescent protein (GFP).

Authors:  B P Cormack; R H Valdivia; S Falkow
Journal:  Gene       Date:  1996       Impact factor: 3.688

7.  p21 contains independent binding sites for cyclin and cdk2: both sites are required to inhibit cdk2 kinase activity.

Authors:  R Fotedar; P Fitzgerald; T Rousselle; D Cannella; M Dorée; H Messier; A Fotedar
Journal:  Oncogene       Date:  1996-05-16       Impact factor: 9.867

8.  Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins.

Authors:  M Hall; S Bates; G Peters
Journal:  Oncogene       Date:  1995-10-19       Impact factor: 9.867

9.  Transcriptional activation by tetracyclines in mammalian cells.

Authors:  M Gossen; S Freundlieb; G Bender; G Müller; W Hillen; H Bujard
Journal:  Science       Date:  1995-06-23       Impact factor: 47.728

10.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

Authors:  J W Harper; G R Adami; N Wei; K Keyomarsi; S J Elledge
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

View more
  2 in total

1.  Identification and characterization of a drug-sensitive strain enables puromycin-based translational assays in Saccharomyces cerevisiae.

Authors:  Gregory A Cary; Sung Hwan Yoon; Cecilia Garmendia Torres; Kathie Wang; Michelle Hays; Catherine Ludlow; David R Goodlett; Aimée M Dudley
Journal:  Yeast       Date:  2014-03-19       Impact factor: 3.239

2.  Down-regulation of the inhibitor of growth 1 (ING1) tumor suppressor sensitizes p53-deficient glioblastoma cells to cisplatin-induced cell death.

Authors:  Ute Gesche Tallen; Matthias Truss; Frank Kunitz; Sven Wellmann; Brad Unryn; Brigitte Sinn; Ulrike Lass; Sonja Krabbe; Nikola Holtkamp; Christian Hagemeier; Reinhard Wurm; Guenter Henze; Karl T Riabowol; Andreas von Deimling
Journal:  J Neurooncol       Date:  2007-09-01       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.